Cox-2 Inhibitors Current Events | Cox-2 Inhibitors News | 9
|
| Page
9 of
20 |
396 Results |
|
|
|
Sort By:
Page Views | Date |
Leeches provide source for cardiovascular drugs
The leech has recently confirmed its biomedical interest for scientists by showing that it contains an extensive list of new potential molecules that may become useful tools in the treatment of cardiovascular diseases. view more (2005-10-26)
Johns Hopkins scientists discover what drives the development of a fatal form of malaria
Platelets - those tiny, unassuming cells that cause blood to clot and scabs to form when you cut yourself - play an important early role in promoting cerebral malaria, an often lethal complication that occurs mostly in children. view more (2008-08-19)
DRUG TREATMENT HOPE FOR DEMENTIA (pp 2024, 2031)
The drug rivastigmine may significantly alleviate the symptoms of a common form of dementia, concludes research published in this week's issue of THE LANCET. Dementia with Lewy bodies (DLB) is a common form of dementia in older people, affecting between 15 and 25% of all cases. It is characterised by fluctuating cognitive impairment, attention... view more... (2000-12-13)
Drugs to bulk up muscles may make injuries more likely
Block the action of a protein that normally regulates muscle mass, and watch your muscles grow. view more (2008-01-23)
NEW THERAPEUTIC APPROACH TO CORONARY STENTING (p 2037)
Patients given stent implantation to treat coronary heart disease could benefit from a new therapeutic approach with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide, concludes research published in this week's issue of THE LANCET. The platelet glycoprotein IIb/IIIa inhibitors are potent inhibitors of blood clotting. They have previously... view more... (2000-12-13)
The unknown risks of arthritis
Arthritis, in particular rheumatoid arthritis (RA), has devastating effects on the body, causing many debilitating effects and leaving many patients immobile or able to function normally. view more (2006-06-26)
Aspirin and similar drugs may be associated with brain microbleeds in older adults
Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain. view more (2009-04-14)
Molds for Molecules
Molecular imprints in polymers as reaction vessels for pharmaceuticals research Materials with the tiniest of cavities, which can take up other molecules as "guests", play a meaningful role in science and technology. A particularly interesting process for the synthesis of materials with precisely fitted cavities is known as molecular imprinting.... view more... (2002-11-28)
Food peptides activate bitter taste receptors
Researchers from the Monell Center and Tokyo University of Agriculture have used a novel molecular method to identify chemical compounds from common foods that activate human bitter taste receptors. view more (2008-01-23)
Common Pain Relievers May Dilute Power of Flu Shots
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system. view more (2009-11-04)
Treatment extends survival in mouse model of spinal muscular atrophy
Drug therapy can extend survival and improve movement in a mouse model of spinal muscular atrophy (SMA), new research shows. The study, carried out at the NIH's National Institute of Neurological Disorders and Stroke (NINDS), suggests that similar drugs might one day be useful for treating human SMA. view more (2007-02-23)
Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center. view more (2008-05-16)
Myostatin inhibitors may improve recovery of wartime limb injuries
Inhibiting a growth factor that keeps muscles from getting too big may optimize recovery of injured soldiers, researchers say. view more (2008-07-09)
Blue-Green Algal Links to Alzheimer's-Like Neurological Disease
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease. view more (2005-04-05)
Bronchial thermoplasty offers significant improvement for asthmatics in small study
Asthmatic patients showed significant improvement in peak expiratory flow, airway responsiveness and number of symptom-free days after treatment with bronchial thermoplasty, a new procedure designed to reduce the ability of airway smooth muscle to narrow from inflammation. view more (2006-05-01)
Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors. view more (2008-07-29)
Diagnosis of arthritis 5 years earlier in childless women compared to those with children
Nulliparous women (those who have not given birth to children) are diagnosed with chronic arthritides (including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) an average of 5.2 years before parous women (those who have given birth to children). view more (2009-06-12)
Penn researchers discover key to how SARS virus infects cells
Researchers from the University of Pennsylvania School of Medicine have found that inhibitors of an enzyme called cathepsin L prevent the SARS (severe acute respiratory syndrome) virus from entering target cells. SARS is caused by an emergent coronavirus. view more (2005-08-02)
Dementia drugs may put some patients at risk, Queen's study shows
Side effects associated with several commonly-prescribed dementia drugs may be putting elderly Canadians at risk, says Queen's University Geriatrics professor Sudeep Gill. view more (2009-05-28)
Columbia University researchers discover on-off switch for chronic pain
Chronic pain affects approximately 48 million people in the U.S. and current medications are either largely ineffective or have serious side effects. view more (2006-07-20)
|
|
| Page
9 of
20 |
396 Results |
|
|
|
Sort By:
Page Views | Date |
|
